• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Whole Slide Imaging Market to Grow at 17% CAGR from 2022 to 2030; Rising Usage of Whole Slide Imaging in Drug Discovery Process to Usher Growth: The Brainy Insights

Share:

July 5, 2022

As per the report published by The Brainy Insights, the global whole slide imaging market is expected to grow from USD 408.6 million in 2021 to USD 1678.6 million by 2030, at a CAGR of 17% during the forecast period 2022-2030.

The rising popularity of virtual slides as compared to physical slides is driving the growth of the market along with the technological advancements in whole slide imaging. But the high investment in the maintenance and procurement of the technologically advanced whole slide imaging products is restraining the market’s growth. However, the development in the technology of whole slide imaging products is expected to increase the adoption rate of the whole slide imaging system in the healthcare sector. It will offer immense opportunities for market growth during the forecast period. The challenge faced by this market includes the lack of skilled personnel for operating the equipment of the whole slide imaging.

Competitive Strategy

To enhance their market position in the global whole slide imaging market, the key players are now focusing on adopting the strategies such as product innovations, mergers & acquisitions, recent developments, joint ventures, collaborations, and partnerships.

● In May 2019, Leica Biosystems’ Aperio AT2 DX System, a digital pathology system, received FDA approval. Aperio AT2 DX System is compatible with whole slide imaging systems.

Market Growth & Trends

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

With technological advancements in digital pathology, the usage of digital slides increased for studying the disease condition accurately. Artificial intelligence technology is being used for assisting computers with precise research on the development of medicines. As per a research report by the World Health Organization (WHO), around 69% of deaths in low- and middle-income countries happen due to cancer. Breast cancers and lung cancer are reportedly the most dominant types of cancer globally. The increasing research and development activities for cancer treatment andpersonalized medicines are driving the growth of the whole slide imaging market, especially for breast cancer treatment.

Source: Finance.Yahoo

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Population Health Management Enters An Uncharted New EraPopulation Health Management Enters An Uncharted New Era
  • Abridge Raises $30M for Generative AI Scribe to Tackle Clinician BurnoutAbridge Raises $30M for Generative AI Scribe to Tackle Clinician Burnout
  • Azurity Pharmaceuticals to Acquire and Merge with Arbor PharmaceuticalsAzurity Pharmaceuticals to Acquire and Merge with Arbor Pharmaceuticals
  • Caregiver Inc. to Acquire Mosaic Services in TexasCaregiver Inc. to Acquire Mosaic Services in Texas
  • Could Hybrid Care Fix Healthcare’s Access Problem?Could Hybrid Care Fix Healthcare’s Access Problem?
  • MOBILion Partners with BOKU Vienna to Introduce High-Resolution Ion Mobility in EuropeMOBILion Partners with BOKU Vienna to Introduce High-Resolution Ion Mobility in Europe
  • Oxalert EPO™ Wearable Device Granted FDA Breakthrough StatusOxalert EPO™ Wearable Device Granted FDA Breakthrough Status
  • Abbott’s Device-Controlled Deep Brain Stimulation System Receives Expanded Indication for Parkinson’s TreatmentAbbott’s Device-Controlled Deep Brain Stimulation System Receives Expanded Indication for Parkinson’s Treatment

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications